Cite

HARVARD Citation

    Mendell, J. et al. (n.d.). AVXS-101 Phase 1 gene therapy clinical trial in SMA Type 1: Event free survival and achievement of developmental milestones. European journal of paediatric neurology. pp. e13-e14. [Online]. 
  
Back to record